Rheumatism is an auto-immune disease which affects joints, soft tissues, autoimmune diseases, vasculitides, and connective tissues. The study of the disorders associated with them is generally referred to as Rheumatology. Rheumatology is a branch of immunology. One of the major changes in modern Rheumatology is the development of new drugs called biologic or disease-modifying agents, which can control severe disease more effectively.
A connective tissue disease is any disease that has the connective tissues of the body as a target of pathology. These disorders can be inherited or acquired, and can present with a wide range of systemic inflammation and immunological features. The autoimmune connective tissue diseases include systemic lupus erythematosus, rheumatoid arthritis, scleroderma, polymyositis, and dermatomyositis.
‘Journal of Rheumatology and Connective Tissue Diseases’ is a peer-reviewed bimonthly journal which features articles on the etiology and complications of rheumatic and connective tissue diseases.
‘Journal of Rheumatology and Connective Tissue Diseases’ is committed to publishing practical information on patient care in rheumatism and associated connective tissue disorders in a clinically presented format. The journal aims to provide timely commitment, relevant coverage of the topics in the current research. The journal’s main scope is to publish latest research on rheumatic and connective tissue diseases.
‘Journal of Rheumatology and Connective Tissue Diseases’ publishes Original research papers, Reviews, Perspectives, Rapid Communication, Short Communications, Mini reviews and Commentaries, Letter to editors, Case blogs etc.